View ValuationGem Aromatics 将来の成長Future 基準チェック /06現在、 Gem Aromaticsの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長19.4%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • May 18Gem Aromatics Limited to Report Q4, 2026 Results on May 21, 2026Gem Aromatics Limited announced that they will report Q4, 2026 results on May 21, 2026Valuation Update With 7 Day Price Move • Mar 27Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹145, the stock trades at a trailing P/E ratio of 27.1x. Average trailing P/E is 20x in the Chemicals industry in India.New Risk • Mar 13New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹9.24b (US$99.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.9% average weekly change). Profit margins are more than 30% lower than last year (6.1% net profit margin). Market cap is less than US$100m (₹9.24b market cap, or US$99.9m).New Risk • Feb 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Profit margins are more than 30% lower than last year (6.1% net profit margin).Valuation Update With 7 Day Price Move • Feb 03Investor sentiment improves as stock rises 27%After last week's 27% share price gain to ₹193, the stock trades at a trailing P/E ratio of 36x. Average trailing P/E is 22x in the Chemicals industry in India.Reported Earnings • Jan 28Third quarter 2026 earnings released: ₹1.04 loss per share (vs ₹3.74 profit in 3Q 2025)Third quarter 2026 results: ₹1.04 loss per share (down from ₹3.74 profit in 3Q 2025). Revenue: ₹772.5m (down 48% from 3Q 2025). Net loss: ₹49.9m (down 129% from profit in 3Q 2025).New Risk • Jan 28New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.1% Last year net profit margin: 11% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Profit margins are more than 30% lower than last year (6.1% net profit margin). Market cap is less than US$100m (₹7.92b market cap, or US$86.4m).お知らせ • Jan 21Gem Aromatics Limited to Report Q3, 2026 Results on Jan 27, 2026Gem Aromatics Limited announced that they will report Q3, 2026 results on Jan 27, 2026Valuation Update With 7 Day Price Move • Dec 05Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹144, the stock trades at a trailing P/E ratio of 18.6x. Average trailing P/E is 24x in the Chemicals industry in India.New Risk • Nov 24New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹8.84b (US$99.2m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (40% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (7.7% average weekly change). Market cap is less than US$100m (₹8.84b market cap, or US$99.2m).Reported Earnings • Nov 15Second quarter 2026 earnings released: ₹0.04 loss per share (vs ₹3.74 profit in 2Q 2025)Second quarter 2026 results: ₹0.04 loss per share (down from ₹3.74 profit in 2Q 2025). Revenue: ₹905.1m (down 40% from 2Q 2025). Net loss: ₹25.8m (down 115% from profit in 2Q 2025).お知らせ • Oct 16Gem Aromatics Limited to Report Q2, 2026 Results on Nov 13, 2025Gem Aromatics Limited announced that they will report Q2, 2026 results on Nov 13, 2025Reported Earnings • Sep 13First quarter 2026 earnings releasedFirst quarter 2026 results: EPS: ₹1.70. Net income: ₹79.8m (up ₹79.8m from 1Q 2025).お知らせ • Sep 09Gem Aromatics Limited to Report Q1, 2026 Results on Sep 12, 2025Gem Aromatics Limited announced that they will report Q1, 2026 results on Sep 12, 2025Board Change • Aug 28High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Shubhangi Umbarkar was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Gem Aromatics は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測BSE:544491 - アナリストの将来予測と過去の財務データ ( )INR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20254,583280N/AN/AN/A9/30/20254,762405-1,531-211N/A6/30/20254,989528N/AN/AN/A3/31/20255,040534-1,300-249N/A3/31/20244,52550110401N/A3/31/20234,2484478152N/A3/31/20223,420397-229-89N/A3/31/20213,059232-58-4N/Aアナリストによる今後の成長予測収入対貯蓄率: 544491の予測収益成長が 貯蓄率 ( 6.9% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 544491の収益がIndian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 544491の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 544491の収益がIndian市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 544491の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 544491の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/21 12:53終値2026/05/21 00:00収益2025/12/31年間収益2025/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Gem Aromatics Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • May 18Gem Aromatics Limited to Report Q4, 2026 Results on May 21, 2026Gem Aromatics Limited announced that they will report Q4, 2026 results on May 21, 2026
Valuation Update With 7 Day Price Move • Mar 27Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹145, the stock trades at a trailing P/E ratio of 27.1x. Average trailing P/E is 20x in the Chemicals industry in India.
New Risk • Mar 13New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹9.24b (US$99.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (7.9% average weekly change). Profit margins are more than 30% lower than last year (6.1% net profit margin). Market cap is less than US$100m (₹9.24b market cap, or US$99.9m).
New Risk • Feb 03New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Share price has been volatile over the past 3 months (8.5% average weekly change). Profit margins are more than 30% lower than last year (6.1% net profit margin).
Valuation Update With 7 Day Price Move • Feb 03Investor sentiment improves as stock rises 27%After last week's 27% share price gain to ₹193, the stock trades at a trailing P/E ratio of 36x. Average trailing P/E is 22x in the Chemicals industry in India.
Reported Earnings • Jan 28Third quarter 2026 earnings released: ₹1.04 loss per share (vs ₹3.74 profit in 3Q 2025)Third quarter 2026 results: ₹1.04 loss per share (down from ₹3.74 profit in 3Q 2025). Revenue: ₹772.5m (down 48% from 3Q 2025). Net loss: ₹49.9m (down 129% from profit in 3Q 2025).
New Risk • Jan 28New minor risk - Profit margin trendThe company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 6.1% Last year net profit margin: 11% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Minor Risks Profit margins are more than 30% lower than last year (6.1% net profit margin). Market cap is less than US$100m (₹7.92b market cap, or US$86.4m).
お知らせ • Jan 21Gem Aromatics Limited to Report Q3, 2026 Results on Jan 27, 2026Gem Aromatics Limited announced that they will report Q3, 2026 results on Jan 27, 2026
Valuation Update With 7 Day Price Move • Dec 05Investor sentiment deteriorates as stock falls 15%After last week's 15% share price decline to ₹144, the stock trades at a trailing P/E ratio of 18.6x. Average trailing P/E is 24x in the Chemicals industry in India.
New Risk • Nov 24New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: ₹8.84b (US$99.2m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (40% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (7.7% average weekly change). Market cap is less than US$100m (₹8.84b market cap, or US$99.2m).
Reported Earnings • Nov 15Second quarter 2026 earnings released: ₹0.04 loss per share (vs ₹3.74 profit in 2Q 2025)Second quarter 2026 results: ₹0.04 loss per share (down from ₹3.74 profit in 2Q 2025). Revenue: ₹905.1m (down 40% from 2Q 2025). Net loss: ₹25.8m (down 115% from profit in 2Q 2025).
お知らせ • Oct 16Gem Aromatics Limited to Report Q2, 2026 Results on Nov 13, 2025Gem Aromatics Limited announced that they will report Q2, 2026 results on Nov 13, 2025
Reported Earnings • Sep 13First quarter 2026 earnings releasedFirst quarter 2026 results: EPS: ₹1.70. Net income: ₹79.8m (up ₹79.8m from 1Q 2025).
お知らせ • Sep 09Gem Aromatics Limited to Report Q1, 2026 Results on Sep 12, 2025Gem Aromatics Limited announced that they will report Q1, 2026 results on Sep 12, 2025
Board Change • Aug 28High number of new directorsThere are 5 new directors who have joined the board in the last 3 years. Independent Director Shubhangi Umbarkar was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.